Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses

Go back to Pfizer (PFE) and BioNtech (BNTX) Announces Study Shows Omicron Variant is Neutralized by Their COVID-19 Vaccine With Three Doses

Pfizer and BioNTech Provide Update on Omicron Variant

December 8, 2021 6:54 AM EST

Preliminary laboratory studies demonstrate that three doses of the Pfizer-BioNTech COVID-19 Vaccine neutralize the Omicron variant (B.1.1.529 lineage) while two doses show significantly reduced neutralization titers Data indicate that a third dose of BNT162b2 increases the neutralizing antibody titers by 25-fold compared to two doses against the Omicron variant; titers after the booster dose are comparable to titers observed after two doses against the wild-type virus which are associated with high levels of protection As 80% of epitopes in the spike protein recognized by CD8+ T cells are not... More